High Definition Dentistry® | Robert B. Gerber D.D.S. | Los Angeles Dentist High Definition Dentistry® | Robert B. Gerber D.D.S. | Los Angeles Dentist

High Definition Dentistry® can provide the ultimate solution to your smile problem so that in the years to come, your smile can continue to reflect your inner beauty.

Robert B. Gerber D.D.S. | Los Angeles Dentist | Director of the Tower Dental Group, Tower Dental Implant Center at The Cedars-Sinai Medical Office Towers in Los Angeles, California.

Oral Cancer Screening - ViziLite Plus™

Screening technology to fight against oral cancer. ViziLite Plus™ is an exciting and revolutionary aid for early detection of abnormalities.

High-Definition Dentistry® uses the new
ViziLite Plus™ screening technology to fight against oral cancer.

ViziLite Plus | Early detection of oral cancer can increase survivability

Every hour of every day in the United States, one American dies of oral cancer.

This deadly disease is the sixth-leading cause of cancer deaths, with no significant improvement in the survival rate in the past 40 years.

In fact, while the American Cancer Society recently reported that overall cancer deaths and incidence have decreased, the oral cancer death rate increased by 5.8 percent, and the incidence increased by 1.5 percent.

If discovered in its early stages,
oral cancer is 90 percent curable,
but less than 50 percent curable in its later stages.

ViziLite Plus | Early detection of oral cancer can increase survivability

To help achieve early detection, Dr. Gerber offers patients the benefits of ViziLite Plus with the TBlue 630 Oral Lesion Identification and Marking System, a technology cleared by the FDA for identifying oral abnormalities in patients at increased risk for oral cancer. ViziLite Plusis a medical breakthrough that helps professionals detect oral abnormalities that could be early indicators of cancer.

The test was developed to improve the traditional
method of detecting oral abnormalities.

Once precancer or cancer can be seen or felt by a health-care practitioner, it has possibly already advanced to the late stages, where it is considerably less curable. In fact, 70 percent of oral cancer lesions detected with traditional visual and tactile exams are detected late, in stage III or IV, when the five-year survival rate is 57 percent.

ViziLite Plus™ is an easy, painless, and noninvasive examination.

It is a three-step process that takes only a few minutes. First, the patient rinses with a raspberry-vinegar flavored solution for one minute, and then the dentist activates the ViziLite Plus light wand, which is a low-energy blue light, and then shines the light in the patient's mouth while examining all the oral tissues for abnormalities. Abnormal tissue will glow a blue--white color. Once Dr. Gerber has ruled out trauma as a cause, the TBlue 630 Oral Lesion Marking System, a bluish dye will be applied to any suspicous area to visualize the precise extent of the lesion.

ViziLite Plus™ is an exciting and revolutionary aid for early detection of abnormalities.

It is my hope that we can save lives by detecting this disease when it is still curable. I believe it may be recognized as important as other screening exams, such as mammography and Pap smears.